135 related articles for article (PubMed ID: 2639912)
1. MHC class I and II antigens on gastric carcinomas and autologous mucosa.
Ferron A; Perez-Ayala M; Concha A; Cabrera T; Redondo M; Oliva MR; Ruiz-Cabello F; Garrido F
J Immunogenet; 1989; 16(4-5):413-23. PubMed ID: 2639912
[TBL] [Abstract][Full Text] [Related]
2. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
López-Nevot MA; Esteban F; Ferrón A; Gutiérrez J; Oliva MR; Romero C; Huelin C; Ruiz-Cabello F; Garrido F
Br J Cancer; 1989 Feb; 59(2):221-6. PubMed ID: 2649129
[TBL] [Abstract][Full Text] [Related]
3. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
[TBL] [Abstract][Full Text] [Related]
5. Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.
Maiorana A; Cesinaro AM; Fano RA; Collina G
Clin Exp Metastasis; 1995 Jan; 13(1):43-8. PubMed ID: 7820955
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
7. Expression of HLA-D sub-region products on human colorectal carcinoma.
Ghosh AK; Moore M; Street AJ; Howat JM; Schofield PF
Int J Cancer; 1986 Oct; 38(4):459-64. PubMed ID: 2428757
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer.
Shen YQ; Zhang JQ; Miao FQ; Zhang JM; Jiang Q; Chen H; Shan XN; Xie W
World J Gastroenterol; 2005 Jun; 11(23):3628-31. PubMed ID: 15962390
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA class I and class II in gastric carcinoma in relation to pathologic stage.
Klein B; Klein T; Nyska A; Shapira J; Figer A; Schwartz A; Rakovsky E; Livni E; Lurie H
Tumour Biol; 1991; 12(2):68-74. PubMed ID: 2028181
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
Esteban F; Concha A; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(5):297-303. PubMed ID: 2076309
[TBL] [Abstract][Full Text] [Related]
11. Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma.
Koyama S; Ebihara T; Fukao K
J Cancer Res Clin Oncol; 1992; 118(8):609-14. PubMed ID: 1355484
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
Degener T; Momburg F; Möller P
Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
14. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.
Gutierrez J; López-Nevot MA; Cabrera T; Oliva R; Esquivias J; Ruiz-Cabello F; Garrido F
Exp Clin Immunogenet; 1987; 4(3):144-52. PubMed ID: 2856203
[TBL] [Abstract][Full Text] [Related]
15. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.
López-Nevot MA; Garcia E; Romero C; Oliva MR; Serrano S; Garrido F
Exp Clin Immunogenet; 1988; 5(4):203-12. PubMed ID: 3078572
[TBL] [Abstract][Full Text] [Related]
17. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order.
Erlich H; Lee JS; Petersen JW; Bugawan T; DeMars R
Hum Immunol; 1986 Jun; 16(2):205-19. PubMed ID: 3459724
[TBL] [Abstract][Full Text] [Related]
19. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
20. Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma.
D'Alessandro G; Zardawi I; Grace J; McCarthy WH; Hersey P
Pathology; 1987 Oct; 19(4):339-46. PubMed ID: 3328139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]